• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparative Hydrophobicity, Solubility, and Metabolic Stability of 4(1)-Pyridones, 4(1)-Quinolones, and 9(10)-Acridones.4(1)-吡啶酮、4(1)-喹诺酮和9(10)-吖啶酮的疏水性、溶解度及代谢稳定性比较
ACS Med Chem Lett. 2025 Mar 24;16(4):583-587. doi: 10.1021/acsmedchemlett.4c00618. eCollection 2025 Apr 10.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Topical versus systemic antibiotics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗生素与全身用抗生素对比
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013053. doi: 10.1002/14651858.CD013053.pub3.
4
Antibiotics versus topical antiseptics for chronic suppurative otitis media.抗生素与外用消毒剂治疗慢性化脓性中耳炎的比较
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013056. doi: 10.1002/14651858.CD013056.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Topical antibiotics with steroids for chronic suppurative otitis media.用于慢性化脓性中耳炎的含类固醇局部用抗生素
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013054. doi: 10.1002/14651858.CD013054.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.

本文引用的文献

1
Medium-Ring Keto Bislactams with Antischistosomal Activity.具有抗血吸虫活性的中环酮双内酰胺。
J Med Chem. 2024 Oct 24;67(20):18235-18246. doi: 10.1021/acs.jmedchem.4c01532. Epub 2024 Oct 8.
2
Late-Stage Saturation of Drug Molecules.药物分子晚期饱和。
J Am Chem Soc. 2024 May 1;146(17):11866-11875. doi: 10.1021/jacs.4c00807. Epub 2024 Apr 15.
3
Theoretical investigation of tautomerism of 2- and 4-pyridones: origin, substituent and solvent effects.2-吡啶酮和4-吡啶酮互变异构的理论研究:起源、取代基及溶剂效应
Org Biomol Chem. 2023 Dec 20;22(1):144-158. doi: 10.1039/d3ob01588b.
4
Antimalarial Dibenzannulated Medium-Ring Keto Lactams.抗疟二苯并稠合中环酮内酰胺
ACS Infect Dis. 2023 Oct 13;9(10):1964-1980. doi: 10.1021/acsinfecdis.3c00245. Epub 2023 Sep 11.
5
Recent Advances of Pyridinone in Medicinal Chemistry.吡啶酮在药物化学中的最新进展
Front Chem. 2022 Mar 23;10:869860. doi: 10.3389/fchem.2022.869860. eCollection 2022.
6
Dose Number as a Tool to Guide Lead Optimization for Orally Bioavailable Compounds in Drug Discovery.剂量数作为指导口服生物利用化合物药物发现中先导化合物优化的工具。
J Med Chem. 2022 Feb 10;65(3):1685-1694. doi: 10.1021/acs.jmedchem.1c01687. Epub 2022 Jan 21.
7
Pyridones in drug discovery: Recent advances.吡喃酮类化合物在药物发现中的研究进展:近期进展
Bioorg Med Chem Lett. 2021 Apr 15;38:127849. doi: 10.1016/j.bmcl.2021.127849. Epub 2021 Feb 18.
8
Fsp: A new parameter for drug-likeness.Fsp:一个新的类药性参数。
Drug Discov Today. 2020 Oct;25(10):1839-1845. doi: 10.1016/j.drudis.2020.07.017. Epub 2020 Jul 24.
9
Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites.强效四氢喹诺酮类药物消除顶复门寄生虫。
Front Cell Infect Microbiol. 2020 Jun 9;10:203. doi: 10.3389/fcimb.2020.00203. eCollection 2020.
10
Tricyclic Imidazolidin-4-ones by Witkop Oxidation of Tetrahydro-β-carbolines.通过四氢-β-咔啉的维特科普氧化反应合成三环咪唑啉-4-酮
J Org Chem. 2020 Feb 21;85(4):2846-2853. doi: 10.1021/acs.joc.9b03402. Epub 2020 Jan 10.

4(1)-吡啶酮、4(1)-喹诺酮和9(10)-吖啶酮的疏水性、溶解度及代谢稳定性比较

Comparative Hydrophobicity, Solubility, and Metabolic Stability of 4(1)-Pyridones, 4(1)-Quinolones, and 9(10)-Acridones.

作者信息

Ren Rongguo, Zhong Longjin, Noack Cassandra, Kaushik Deepender, Leas Derek A, Wang Xiaofang, Dong Yuxiang, Charman Susan A, Vennerstrom Jonathan L

机构信息

College of Pharmacy, University of Nebraska Medical Center, 986125 Nebraska Medical Center, Omaha, Nebraska 68198-6025, United States.

Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.

出版信息

ACS Med Chem Lett. 2025 Mar 24;16(4):583-587. doi: 10.1021/acsmedchemlett.4c00618. eCollection 2025 Apr 10.

DOI:10.1021/acsmedchemlett.4c00618
PMID:40236529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11995228/
Abstract

The relatively polar 4(1)-pyridone (4-pyridone) heterocycle is found in many drugs and drug candidates. In a comparison of the hydrophobicity, aqueous solubility, and metabolic stability of several matched sets of 4-pyridones, 4(1)-quinolones (4-quinolones), and 9(10)-acridones (9-acridones), measured chromatographic log values show that 9-acridones are more hydrophobic and less soluble than their 4-quinolone and 4-pyridone counterparts. All 4-pyridone/4-quinolone pairs had identical or very similar hydrophobicity and aqueous solubility properties. Metabolic stability increased steadily from 9-acridones to 4-quinolones to 4-pyridones, consistent with the progressive increase in Fsp values and log . The gain in metabolic stability was not as great for those 4-pyridone/4-quinolone pairs featuring additional polar functional groups/heterocycles.

摘要

相对极性的4(1)-吡啶酮(4-吡啶酮)杂环存在于许多药物及候选药物中。在对几组匹配的4-吡啶酮、4(1)-喹诺酮(4-喹诺酮)和9(10)-吖啶酮(9-吖啶酮)的疏水性、水溶性及代谢稳定性进行比较时,测得的色谱log 值表明,9-吖啶酮比其对应的4-喹诺酮和4-吡啶酮更疏水且溶解度更低。所有4-吡啶酮/4-喹诺酮对具有相同或非常相似的疏水性和水溶性特性。代谢稳定性从9-吖啶酮到4-喹诺酮再到4-吡啶酮稳步增加,这与Fsp值和log 的逐渐增加一致。对于那些具有额外极性官能团/杂环的4-吡啶酮/4-喹诺酮对,代谢稳定性的增加幅度没有那么大。